Brief: Oncozenge Gets European Regulatory Approval To Start Pivotal Phase III Trial Of Bupizenge
26/05/2026 10:24
May 26 (Reuters) - Oncozenge AB ONCOZ.ST: ONCOZENGE RECEIVES EUROPEAN REGULATORY APPROVAL TO START PIVOTAL PHASE III TRIAL OF BUPIZENGE™ Source text: ID:nMFN9NkmB5 Further company coverage: ONCOZ.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com;))